Regional trends in the use of steroids and favipiravir for COVID-19 treatment
Background: Infectious diseases are treated based on clinical guidelines, which usually require a large amount of data and time to formulate. Therefore, various treatments are tried and used in the early stages of epidemics of emerging and reemerging infectious diseases. In this study, we focused on...
Main Authors: | Yusuke Asai, Shinya Tsuzuki, Nobuaki Matsunaga, Norio Ohmagari |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034122003641 |
Similar Items
-
The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment
by: Servet ÖZTÜRK, et al.
Published: (2021-12-01) -
Serial computed tomography findings of Coronavirus disease 2019 (COVID-19) pneumonia treated with favipiravir and steroid therapy: report of 11 cases
by: Naoki Irizato, et al.
Published: (2021-05-01) -
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
by: Hitoshi Yamamura, et al.
Published: (2020-07-01) -
Hematological Malignancy Patients, COVID-19, and Favipiravir
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-12-01) -
Evaluation of the effect of favipiravir on patients with COVID-19
by: Alireza Kamali, et al.
Published: (2023-01-01)